Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB9BP1 is classified as a **pseudogene** derived from the RAB9B gene and does not encode a functional protein[3]. Pseudogenes are typically DNA sequences similar to known genes but lack coding ability due to mutations or deletions. The functional protein-coding gene is **RAB9B, member of the RAS oncogene family**, which encodes a small GTPase involved in *intracellular membrane trafficking*, particularly in late endosome to trans-Golgi transport, but **RAB9BP1 itself is not functionally active and has no known therapeutic, biological, or disease-associated roles**[3]. **Additional clarification:** - The functional gene *RAB9B* (not the pseudogene RAB9BP1) is involved in GTP binding and GTPase activity, with roles in vesicle and protein transport, and it is being studied in cancer but **RAB9BP1** is not functionally relevant[1][5][6][7]. - If the query intended a protein-coding target, the correct entry would be **RAB9B, member RAS oncogene family**—abbreviated as **RAB9B**—which is a small GTPase and potential cancer biomarker, whereas RAB9BP1 (the pseudogene) is generally not considered in pharmacological or mechanistic contexts[2]. **Summary:** **RAB9BP1** is a pseudogene and **not a protein-coding therapeutic target**. If you are seeking information about the protein-coding RAB9B (not the pseudogene), you should refer to data for "RAB9B, member RAS oncogene family" (RAB9B), a small GTPase involved in membrane trafficking and potentially implicated in cancer progression[2][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB9B, member RAS oncogene family pseudogene 1 (RAB9BP1).